Comparative effects of overproducing the AraC-type transcriptional regulators MarA, SoxS, RarA and RamA on antimicrobial drug susceptibility in Klebsiella pneumoniae by Jiménez-Castellanos, Juan-Carlos et al.
                          Jiménez-Castellanos, J-C., Wan Ahmad Kamil, W. N. I., Cheung, C. H. P.,
Tobin, M. S., Brown, J., Isaac, S. G., ... Avison, M. B. (2016). Comparative
effects of overproducing the AraC-type transcriptional regulators MarA,
SoxS, RarA and RamA on antimicrobial drug susceptibility in Klebsiella
pneumoniae. Journal of Antimicrobial Chemotherapy, 71(7), 1820-1825.
DOI: 10.1093/jac/dkw088
Peer reviewed version
Link to published version (if available):
10.1093/jac/dkw088
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via Oxford University Press at https://academic.oup.com/jac/article-lookup/doi/10.1093/jac/dkw088. Please refer
to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
 1 
SUPPLEMENTARY INFORMATION 
 
Comparative effects of Overproducing the AraC-Type Transcriptional Regulators 
MarA, SoxS, RarA and RamA on Antimicrobial Drug Susceptibility in Klebsiella 
pneumoniae. 
 
Juan-Carlos JIMÉNEZ-CASTELLANOSa, Wan Nur Ismah WAN AHMAD KAMILa,b, Ching Hei Phoebe 
CHEUNGa, Maryann S. TOBINa, James BROWNa,*, Sophie G. ISAACa, Kate J. HEESOMc, Thamarai 
SCHNEIDERSd & Matthew B. AVISONa,‡ 
 
aSchool of Cellular and Molecular Medicine University of Bristol, Bristol, United Kingdom  
bFaculty of Biotechnology & Biomolecular Sciences, Universiti Putra Malaysia, Selangor Darul 
Ehsan, Malaysia. 
cBristol University Proteomics Facility, University of Bristol, Bristol, United Kingdom. 
dDivision of Infection and Pathway Medicine, University of Edinburgh, Edinburgh, United 
Kingdom. 
Corresponding author. Mailing address: School of Cellular and Molecular Medicine, University 
of Bristol, Medical Sciences Building, University Walk, Bristol, BS8 1TD, United Kingdom. Tel: 
+44(0)1173312036, Fax +44(0)1179287896. E-mail: Matthewb.Avison@bristol.ac.uk.  
 
 
 2 
SUPPLEMENTARY METHODS 
OMP and Proteomic Analysis 
Cells were pelleted by centrifugation (10 min, 4,000 × g, 4˚C) and resuspended in 20 mL of 30 
mM Tris-HCl, pH 8 and broken by sonication using a cycle of 1 sec on, 0.5 sec off for 3 min at 
amplitude of 63% using a Sonics Vibracell VC-505TM (Sonics and Materials Inc., Newton, 
Connecticut, USA). The sonicated samples were centrifuged at 8,000 rpm (Sorval RC5B PLUS 
using an SS-34 rotor) for 15 min at 4˚C to pellet intact cells and large cell debris. The 
supernatant was removed and subjected to centrifugation at 20,000 rpm for 60 min at 4˚C 
using the above rotor to pellet total envelopes. If OMPs were to be purified, inner membranes 
and associated proteins were removed from the total envelope pellet by adding 100 μL of 20% 
w/v n-lauryl sarcosine and incubating at room temperature for 20 min. The sarcosine-insoluble 
outer membranes were recovered by centrifugation as above, and the pellet solubilised in 100 
μL of water. To isolate total envelope proteins, the total envelope pellet (above) was solubilised 
using 200 μL of 30 mM Tris-HCl pH 8 containing 0.5% (w/v) SDS.  
The protein concentration in each sample was quantified using Biorad Protein Assay Dye 
Reagent Concentrate according to the manufacturer’s instructions. Proteins (5 μg/lane for total 
envelope proteomics; 1 μg/lane for OMP analyses) were separated by SDS-PAGE using 11% 
acrylamide, 0.5% bis-acrylamide (Biorad) gels and a Biorad Min-Protein Tetracell chamber 
model 3000X1. For the proteomics experiments only, gels containing total envelope proteins 
were run at 200 V until the dye front had moved approximately 1 cm into the separating gel; for 
OMP analyses, the dye front was run off the bottom of the gel. Proteins in all gels were stained 
with Instant Blue (Expedeon) for 20 min and de-stained in water.  
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For total envelope proteomics, the one centimeter of gel lane containing total envelope 
proteins was cut out and subjected to in-gel tryptic digestion using a ProGest automated 
digestion unit (Digilab UK).  The resulting peptides were fractionated using an Ultimate 3000 
nanoHPLC system in line with an LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific). In 
brief, peptides in 1% (v/v) formic acid were injected onto an Acclaim PepMap C18 nano-trap 
column (Thermo Scientific). After washing with 0.5% (v/v) acetonitrile plus 0.1% (v/v) formic 
acid, peptides were resolved on a 250 mm × 75 μm Acclaim PepMap C18 reverse phase 
analytical column (Thermo Scientific) over a 150 min organic gradient, using 7  gradient 
segments (1-6% solvent B over 1 min., 6-15% B over 58 min., 15-32% B over 58 min., 32-40% B 
over 3 min., 40-90% B over 1 min., held at 90% B for 6 min and then reduced to 1% B over 1 
min.) with a flow rate of 300 nl.min−1.  Solvent A was 0.1% formic acid and Solvent B was 
aqueous 80% acetonitrile in 0.1% formic acid.  Peptides were ionized by nano-electrospray 
ionization at 2.1 kV using a stainless steel emitter with an internal diameter of 30 μm (Thermo 
Scientific) and a capillary temperature of 250°C. Tandem mass spectra were acquired using an 
LTQ-Orbitrap Velos mass spectrometer controlled by Xcalibur 2.1 software (Thermo Scientific) 
and operated in data-dependent acquisition mode. The Orbitrap was set to analyze the survey 
scans at 60,000 resolution (at m/z 400) in the mass range m/z 300 to 2000 and the top twenty 
multiply charged ions in each duty cycle selected for MS/MS in the LTQ linear ion trap. Charge 
state filtering, where unassigned precursor ions were not selected for fragmentation, and 
dynamic exclusion (repeat count, 1; repeat duration, 30 s; exclusion list size, 500) were used. 
Fragmentation conditions in the LTQ were as follows: normalized collision energy, 40%; 
activation q, 0.25; activation time 10 ms; and minimum ion selection intensity, 500 counts. 
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The raw data files were processed and quantified using Proteome Discoverer software v1.2 
(Thermo Scientific) and searched against the UniProt K. pneumoniae strain ATCC 700721 / MGH 
78578 database (5126 protein entries; UniProt accession 272620) using the SEQUEST (Ver. 28 
Rev. 13) algorithm. Peptide precursor mass tolerance was set at 10 ppm, and MS/MS tolerance 
was set at 0.8 Da. Search criteria included carbamidomethylation of cysteine (+57.0214) as a 
fixed modification and oxidation of methionine (+15.9949) as a variable modification. Searches 
were performed with full tryptic digestion and a maximum of 1 missed cleavage was allowed. 
The reverse database search option was enabled and all peptide data was filtered to satisfy 
false discovery rate (FDR) of 5 %. The Proteome Discoverer software generates a reverse 
“decoy” database from the same protein database used for the analysis and any peptides 
passing the initial filtering parameters that were derived from this decoy database are defined 
as false positive identifications. The minimum cross-correlation factor filter was readjusted for 
each individual charge state separately to optimally meet the predetermined target FDR of 5 % 
based on the number of random false positive matches from the reverse decoy database. Thus 
each data set has its own passing parameters. Protein Area measurements were calculated 
from peptide peak areas using the Top 3 method S1 and were then used to calculate the relative 
abundance of each protein between pBAD transformants. Proteomic analysis was repeated at 
least three times, each using a separate batch of cells. 
 
Quantitative Reverse-Transcriptase PCR. 
RNA in cultures was stabilised using RNAprotect Bacteria Reagent (Qiagen, Crawley, UK) 
according to the manufacturer’s instructions, before 1.5 mL of stabilised culture was 
centrifugation for 5 min at 4000 rpm (Function Line Labofuge 400R centrifuge, Heraeus, Hanau, 
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Germany) to pellet cells. Following aspiration of the supernatant, 200 µL of TE buffer containing 
lysozyme (50 mg/mL) was used to disrupt the pellet, and the mixture was left for 10 min at 
room temperature, vortexing every 2 min before addition of 700 μL RLT buffer (Qiagen) 
containing 150 mM β-mercaptoethanol. The mixture was transferred to a tube containing acid 
washed silica lysing matrix B (MP Biochemicals, Eschwege, Germany) and cells were disrupted 
in a Ribolyser (Hybaid, Basingstoke, UK) (setting 6.0; 2 cycles lasting 45 s each). Following 
disruption, RNA was purified using a Qiagen RNeasy RNA purification kit, according to the 
manufacturer’s instructions. RNA from 1.5 mL of bacterial culture was dissolved in 50 μL RNase 
free water, contaminating genomic DNA was digested using a TURBO DNA-free™ Kit (Ambion, 
Foster City, CA, USA) following the manufacturer’s instructions. The concentration of RNA in 
each sample was measured using a NanoDrop ND-100 spectrophotometer (Labtech, UK). One 
microgram of total RNA was converted into cDNA using qScriptTM reverse transcriptase (Quanta 
Biosciences, Gaithersburg, MD, USA) in a 20 μL reaction which included random hexamer 
primers. The reaction was incubated for 5 min at 25°C, 30 min at 42°C and 5 min at 85°C. cDNA 
samples were stored at -20°C until used as templates for gene-specific real-time qPCR. The 
reference gene in each case was rrsE. Each real-time qPCR reaction was prepared using 100 ng 
of cDNA (quantified by Nanodrop) as template in a 20 μL reaction with PowerUp™ SYBR Green 
Master Mix (Applied Biosystems, Waltham, Massachusetts, USA) and 500 nM of each primer 
(Table S1). The amplification and quantification of cDNA copies was performed using a 
StepOnePlus™ Real-Time PCR System (Applied Biosystems). Samples were run as 4 technical 
replicates and 3 biological replicates were used for each comparison, each from a separate RNA 
purified from a separate batch of cells. The PCR amplification cycles consisted of initial 
denaturation at 95°C for 2 min followed by 40 cycles of denaturation at 95°C for 2 s and 
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annealing/extension at 60°C for 30 s. The ratio of target to reference cDNA in a sample of 
comparator B was calculated relative to that in a sample of comparator A according to the ΔΔCT 
method.S2 In each case, comparator A was a transformant carrying the pBAD control plasmid 
and comparator B was a transformant carrying the pBAD plasmid overexpressing the 
appropriate regulator gene. 
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SUPPLEMENTARY TABLES 
Table S1: PCR and qRT-PCR primers used in this study 
Primer Sequence (5’ to 3’) 
ramA+ ATGACGATTTCCGCTCAG 
ramA- AGCTGGTTGAGACATTCC 
marA+ ATGTCCAGACGTAATAATGAC 
marA- TCATGATTTCCTCAATACGTC 
rarA+  ATGATGAACACTGGCGC 
rarA-  ATCGCTGACGAGATGTC 
soxS+  ATGTCCCATCAGGATATTATTC 
soxS-  TCACGCGGAGATCTGATG 
ompK35+ 
(NcoI site 
underlined) 
CCATGGTGAAGCGCAATATTC 
ompK35- CACTTCGATGTATTTAACCAG 
ompK36+ 
(NcoI site 
underlined) 
CCATGGAAGTTAAAGTACTGT 
ompK36- CAGCTTGCAACTTAGAACTG 
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Table S2. Disc susceptibility assay for K. pneumoniae SM transformants expressing regulator genes 
Antibiotic (μg in disc) 
pBAD(control) 
Zone (mm) 
pBAD(marA) Zone 
[Difference from 
control] (mm) 
pBAD(soxS) Zone 
[Difference from 
control] (mm) 
pBAD(rarA) Zone 
[Difference from 
control] (mm) 
pBAD(ramA) Zone 
[Difference from 
control] (mm) 
Amikacin (30) 23  (S) NC NC NC -2  (S) 
Gentamicin (10) 23  (S) NC NC NC -2  (S) 
Tobramycin (10) 20  (S) NC NC NC NC 
Cefoxitin (30) 26  (S) NC -2  (S) -3  (S) -5  (S) 
Cefuroxime (30) 25  (S) NC -2  (S) -3  (S) -6  (S) 
Ceftriaxone (30) 31  (S) NC NC -2  (S) NC 
Cefotaxime (30) 35  (S) NC -3  (S) -3  (S) -4  (S) 
Ceftazidime (30) 30  (S) -2  (S) -3  (S) -4  (S) -7  (S) 
Cefepime (30) 32  (S) NC NC NC -2  (S) 
Aztreonam (30) 33  (S) NC -2  (S) -4  (S) -3  (S) 
Imipenem (10) 25  (S) NC NC NC NC 
Meropenem (10) 30  (S) NC NC NC NC 
Doripenem (10) 26  (S) NC NC NC NC 
Ciprofloxacin (5) 34  (S) NC -2  (S) -4  (S) -8  (S) 
Norfloxacin (10) 31  (S) NC -3  (S) -3  (S) -7  (S) 
Ofloxacin (5) 31  (S) NC -3  (S) -4  (S) -6  (S) 
Tigecycline (15) 21   NC NC NC -4   
Minocycline (30) 20  (S) NC NC -2  (S) -8  (R) 
Chloramphenicol (30) 28  (S) NC -2  (S) -4  (S) -8  (S) 
Trimethoprim/ 
Sulfamethoxazole 
(1.25/23.75) 
30  (S) NC NC NC -2  (S) 
Assays were performed using Muller Hinton agar with 0.2 % w/v arabinose to stimulate expression of the cloned genes and 50 mg/L 
ampicillin to select for the pBAD plasmids. Otherwise, the assay was performed according to the CLSI protocol.17 Abbreviations used are S: 
Susceptible; I: intermediate Resistant; NC: No Change in zone diameter versus control. Values reported are the means of at least three 
repetitions rounded to the nearest integer. Mean changes <2 mm are reported as NC. Susceptibility breakpoints are as set by the CLSI.20 
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SUPPLEMENTARY FIGURES 
Figure S1: Effect of AraC-type Regulator Over-Production in K. pneumoniae SM on Envelope 
Permeability and OMP profile. 
A: The accumulation of H33342 dye by K. pneumoniae SM transformants overexpressing ramA, 
rarA, soxS or marA is represented as a percentage relative to accumulation in the plasmid-only 
control transformant (set to 100%) over a 30 cycle (45 minute) incubation period. Each graph 
shows mean data for four biological replicates with 8 technical replicates in each, and error 
bars define the standard error of the mean (SEM). B: OMPs were purified from K. pneumoniae 
SM transformants carrying the control plasmid or those overexpressing ramA, rarA, soxS or 
marA. All OMPs were separated using SDS-PAGE and stained as set out in Materials & Methods. 
These data are representative of three biological replicates.  
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Figure S2: Changes in Cefoxitin Zone Diameter Following Overproduction of AraC-type 
regulators in K. pneumoniae NCTC5055. 
A: qRT-PCR analysis of AraC-type regulator gene expression following over-production using the 
pBAD vector with 0.2 % w/v Arabinose as inducer. Samples were collected from Nutrient Broth 
cultures incubated with arabinose for 2 h. B: CLSI antibiotic disc susceptibility testing 17 was 
performed using agar containing different amounts of arabinose designed to induce expression 
of ramA, rarA, soxS or marA in K. pneumoniae NCTC5055 transformants to different degrees. 
The zone diameter across a cefoxitin disc was measured for each transformant and at each 
arabinose concentration and compared with the zone diameter for NCTC5055 carrying the 
control plasmid when grown at the same arabinose concentration. Differences in zone 
diameter in the transformants relative to control are reported in the graph. Data are modes of 
three biological replicates. 
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